The following are contraindications for different classes of oral hypoglycemic drugs.

- **Metformin**: Hypersensitivity to the drug, severe renal dysfunction (eGFR less than 30 mL/minute/1.73 m2), and metabolic acidosis, including diabetic ketoacidosis.

- **Sulfonylureas****:**Hypersensitivity to the drug or sulfonamide derivatives, type 1 diabetes mellitus, and diabetic ketoacidosis.

- **Pioglitazone**: Hypersensitivity to the drug, New York Heart Association Class III or IV heart failure, serious hepatic impairment, bladder cancer, history of macroscopic hematuria, and pregnancy.

- **Alpha-glucosidase inhibitors**: Hypersensitivity to acarbose, diabetic ketoacidosis, cirrhosis, inflammatory bowel disease, ulcers of the intestine, partial intestinal obstruction, digestive and absorptive issues

- **SGLT 2 inhibitors**: History of serious hypersensitivity to the drug, end-stage renal disease (ESRD), and patients on dialysis.

- **DPP-4 inhibitors:**Dose adjustment of saxagliptin is needed for eGFR less than 45 mL/min/1.73 m^2 with the dose of 2.5 mg once daily. For sitagliptin, a low dose of 25 mg daily is given in patients with a creatinine clearance of less than 30 ml/min/1.73 m^2 and is contraindicated in patients on hemodialysis or peritoneal dialysis. Linagliptin does not need any dose adjustment.

- **Cycloset**: Allergy to the drug, breastfeeding, and syncopal migraine